iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionHarbour Capital Advisors, LLC
Latest Disclosed Ownership4,838 shares
Latest Disclosed Value $ 843,554
Harbour Capital Advisors, LLC reports 1.26% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 29, 2026 - Harbour Capital Advisors, LLC filed a 13F-HR form disclosing ownership of 4,838 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $843,554 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 4,778 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 1.26% during the quarter. The current value of the position is $634,020 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,838 60 1.26 844 4.46 0.1607
2026-01-07 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,778 -725 -13.17 807 -2.54 0.1644
2025-10-09 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,503 -60 -1.08 828 15.00 0.1694
2025-07-11 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,563 0 0.00 721 4.65 0.1519
2025-04-23 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,563 -165 -2.88 689 -10.42 0.1703
2025-01-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,728 -50 -0.87 768 -7.13 0.1713
2024-10-16 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,778 120 2.12 827 6.85 0.1908
2024-07-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,658 0 0.00 775 2.25 0.1839
2024-04-16 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,658 0 0.00 758 -1.56 0.1876
2024-01-05 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,658 0 0.00 769 11.29 0.2109
2023-10-05 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,658 0 0.00 692 -3.63 0.2075
2023-07-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,658 0 0.00 717 -1.78 0.2116
2023-04-19 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,658 0 0.00 731 -0.68 0.2209
2023-01-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,658 -105 -1.82 736 8.09 0.2475
2022-10-19 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,763 0 0.00 680 0.29 0.2358
2022-07-20 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,763 0 0.00 678 -9.72 0.2210
2022-04-11 2022-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,763 0 0.00 751 -14.66 0.2055
2022-01-12 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,763 0 0.00 880 -5.58 0.2164
2021-10-13 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,763 -30 -0.52 932 -1.69 0.2453
2021-07-14 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,793 -4 -0.07 948 8.59 0.2546
2021-04-12 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,797 5,797 873 0.2570
2021-01-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -5,879 -100.00 0 -100.00
2020-10-09 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 5,879 0 0.00 796 -1.00 0.2910
2020-07-21 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 5,879 0 0.00 804 27.01 0.3259
2020-04-08 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,879 0 0.00 633 -10.59 0.3218
2020-01-22 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,879 -710 -10.78 708 7.93 0.2713
2019-10-30 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 6,589 -375 -5.38 656 -13.68 0.2774
2019-07-10 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 6,964 -460 -6.20 760 -8.43 0.3258
2019-04-24 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,424 -200 -2.62 830 12.93 0.3666
2019-01-23 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,624 7,624 735 0.3650
2018-11-07 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -8,454 -100.00 0 -100.00
2018-07-11 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,454 -135 -1.57 936 2.07 0.4009
2018-04-18 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,589 -225 -2.55 917 -2.55 0.3903
2018-01-24 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,814 6,131 228.51 941 5.14 0.3906
2017-11-08 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,683 0 0.00 895 7.57 0.3902
2017-08-01 2017-06-30 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 2,683 -185 -6.45 832 -1.07 0.4131
2017-07-27 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 831,945 829,077 2,683
2017-05-15 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 2,868 -75 -2.55 841 7.68 0.3839
2017-02-03 2016-12-31 13F ISHARES TR NASDAQ IBOXX INV CP ETF 464287556 2,943 -17 -0.57 781 -8.87 0.5599
2016-11-09 2016-09-30 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 2,960 -70 -2.31 857 9.87 0.5366
2016-08-26 2016-06-30 13F ISHARES TR NASDAQ ETF 464287556 3,030 0 0.00 780 -1.27 0.4381
2016-09-13 2016-03-31 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 3,030 -65 -2.10 790 -24.55 0.4494
2016-10-03 2015-12-31 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 3,095 0 0.00 1,047 11.50 0.5700
2016-10-12 2015-09-30 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 3,095 0 0.00 939 -17.78 0.6647
2016-10-27 2015-06-30 13F ISHARES TR NASDAQ S&P 100 ETF 464287556 3,095 0 0.00 1,142 7.43 0.7127
2016-11-28 2015-03-31 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 3,095 0 0.00 1,063 13.21 0.7417
2016-12-05 2014-12-31 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 3,095 0 0.00 939 10.86 0.6729
2016-12-19 2014-09-30 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 3,095 0 0.00 847 6.41 0.7000
2016-12-30 2014-06-30 13F ISHARES TR NASDAQ COM 464287556 3,095 0 0.00 796 8.74 0.6252
2017-01-18 2014-03-31 13F ISHARES TR NASDAQ NASDQ BIOTEC ETF 464287556 3,095 240 8.41 732 12.96 0.6934
2017-03-21 2013-12-31 13F ISHARES NASDQ BIOTEC ETF 464287556 2,855 0 0.00 648 8.36 0.5722
2017-06-20 2013-09-30 13F ISHARES NASDQ BIOTEC ETF 464287556 2,855 100 3.63 598 24.84 0.6538
2017-06-20 2013-06-30 13F ISHARES TR NASDQ BIO INDX 464287556 2,755 1,070 63.50 479 78.07 0.6038
2017-06-20 2013-03-31 13F ISHARES TR NASDQ BIO INDX 464287556 1,685 1,685 269 0.4760
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.